Olaparib for Metastatic Castration-Resistant Prostate Cancer

Tinaye Mutetwa; William D. Foulkes; Paz Polak

doi:10.1056/NEJMc2023199

Olaparib for Metastatic Castration-Resistant Prostate Cancer

Tinaye Mutetwa
, William D. Foulkes
, Paz Polak

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	890
Number of pages	1
Journal	New England Journal of Medicine
Volume	383
Issue number	9
DOIs	https://doi.org/10.1056/NEJMc2023199
State	Published - 27 Aug 2020

Access to Document

10.1056/NEJMc2023199

Cite this

@article{358dc732ea91438ba7bbd3551f6b60e1,

title = "Olaparib for Metastatic Castration-Resistant Prostate Cancer",

author = "Tinaye Mutetwa and Foulkes, \{William D.\} and Paz Polak",

note = "Funding Information: Paz Polak, Ph.D. Icahn School of Medicine at Mount Sinai New York, NY Mr. Mutetwa reports receiving a grant (R01CA210806-03S1) from the National Cancer Institute; Dr. Foulkes, receiving grants from the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute and research support from AstraZeneca; and Dr. Polak, receiving support from the V Foundation for Cancer Research. No other potential conflict of interest relevant to this letter was reported.",

year = "2020",

month = aug,

day = "27",

doi = "10.1056/NEJMc2023199",

language = "English",

volume = "383",

pages = "890",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "9",

}

TY - JOUR

T1 - Olaparib for Metastatic Castration-Resistant Prostate Cancer

AU - Mutetwa, Tinaye

AU - Foulkes, William D.

AU - Polak, Paz

N1 - Funding Information: Paz Polak, Ph.D. Icahn School of Medicine at Mount Sinai New York, NY Mr. Mutetwa reports receiving a grant (R01CA210806-03S1) from the National Cancer Institute; Dr. Foulkes, receiving grants from the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute and research support from AstraZeneca; and Dr. Polak, receiving support from the V Foundation for Cancer Research. No other potential conflict of interest relevant to this letter was reported.

PY - 2020/8/27

Y1 - 2020/8/27

UR - https://www.scopus.com/pages/publications/85089967983

U2 - 10.1056/NEJMc2023199

DO - 10.1056/NEJMc2023199

M3 - Letter

C2 - 32846073

AN - SCOPUS:85089967983

SN - 0028-4793

VL - 383

SP - 890

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 9

ER -